We manufacture and provide 379270-35-6 Tenofovir Alafenamide intermediate
CAS 379270-35-6
Purity is ≥ 98%
Tenofovir Alafenamide:
is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir. It was developed by Gilead Sciences for use in the treatment of HIV
infection and chronic hepatitis B, and is applied in the form of tenofovir alafenamide fumarate (TAF).